Press release
Deadline on August 24th coming up in Lawsuit for Investors in shares of Athira Pharma, Inc. (NASDAQ: ATHA)
A Deadline is coming up on August 24, 2021 in the lawsuit for certain investors in Athira Pharma, Inc. (NASDAQ: ATHA).
Investors who purchased shares of Athira Pharma, Inc. (NASDAQ: ATHA) have certain options and there are strict and short deadlines running. Deadline: August 24, 2021. NASDAQ: ATHA stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Western District of Washington the plaintiff alleges on behalf of purchasers of Athira Pharma, Inc. (NASDAQ: ATHA) common shares between September 18, 2020 and June 17, 2021, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims the Registration Statement and that between September 18, 2020 and June 17, 202, the defendants made materially false and misleading statements and omitted to state that Dr. Kawas had published research papers containing improperly altered images while she was a graduate student, that this purported research was foundational to Athira's efforts to develop treatments for Alzheimer's because it laid the biological groundwork that Athira was using in its approach to treating Alzheimer's, that as a result, Athira's intellectual property and product development for the treatment of Alzheimer's was based on invalid research, and that as a result of the foregoing, the defendants' positive statements about Athira's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis. Those who purchased shares of Athira Pharma, Inc. (NASDAQ: ATHA) have certain options and should contact the Shareholders Foundation.
Those who purchased shares of Athira Pharma, Inc. (NASDAQ: ATHA) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on August 24th coming up in Lawsuit for Investors in shares of Athira Pharma, Inc. (NASDAQ: ATHA) here
News-ID: 2340218 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Athira
Lewy Body Dementia Market Set to Grow Substantially Through 2034, DelveInsight P …
DelveInsight's "Lewy Body Dementia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Lewy Body Dementia, historical and forecasted epidemiology as well as the Lewy Body Dementia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Lewy Body Dementia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Lewy Body Dementia Market…
Lewy Body Dementia Market to Show Remarkable Growth Trends from 2024 to 2034, De …
DelveInsight's "Lewy Body Dementia Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Lewy Body Dementia, historical and forecasted epidemiology as well as the Lewy Body Dementia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Lewy Body Dementia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Lewy Body Dementia Market…
Parkinson's Disease Psychosis Drugs Market Size 2032 | Vanda Pharmaceuticals, Ky …
DelveInsight's "Parkinson's disease psychosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Parkinson's disease psychosis, historical and forecasted epidemiology as well as the Parkinson's disease psychosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Key Takeaways from the Parkinson's Disease Psychosis Market Report
• According to DelveInsight analysis, the Parkinson's disease psychosis market is anticipated to increase at a…
Investigation announced for Investors in Athira Pharma, Inc. (NASDAQ: ATHA) over …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Athira Pharma, Inc.
Investors who purchased shares of Athira Pharma, Inc. (NASDAQ: ATHA) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Athira Pharma, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
…
Athira Pharma, Inc. (NASDAQ: ATHA) Investor Notice: Update in Lawsuit
The Shareholders Foundation announced an update in the lawsuit that was filed on behalf of certain investors in Athira Pharma, Inc. (NASDAQ: ATHA).
If you purchased shares of Athira Pharma, Inc. (NASDAQ: ATHA), you have certain options and you should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On June 25, 2021, a lawsuit was filed for investors in shares of Athira Pharma, Inc over alleged…
Investigation announced for Investors in shares of Athira Pharma, Inc. (NASDAQ: …
An investigation was announced on behalf of current long-term investors in shares of Athira Pharma, Inc. (NASDAQ: ATHA) concerning potential breaches of fiduciary duties by certain directors of Athira Pharma, Inc.
Investors who are current long term investors in Athira Pharma, Inc. (NASDAQ: ATHA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long…
